Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

A calcium channel mutant mouse model of hypokalemic periodic paralysis.

Wu F, Mi W, Hernández-Ochoa EO, Burns DK, Fu Y, Gray HF, Struyk AF, Schneider MF, Cannon SC.

J Clin Invest. 2012 Dec;122(12):4580-91. doi: 10.1172/JCI66091. Epub 2012 Nov 26.

2.

A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.

Wu F, Mi W, Burns DK, Fu Y, Gray HF, Struyk AF, Cannon SC.

J Clin Invest. 2011 Oct;121(10):4082-94. doi: 10.1172/JCI57398. Epub 2011 Sep 1.

3.

Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.

Wu F, Mi W, Cannon SC.

Brain. 2013 Dec;136(Pt 12):3766-74. doi: 10.1093/brain/awt280. Epub 2013 Oct 18.

4.

Disrupted coupling of gating charge displacement to Na+ current activation for DIIS4 mutations in hypokalemic periodic paralysis.

Mi W, Rybalchenko V, Cannon SC.

J Gen Physiol. 2014 Aug;144(2):137-45. doi: 10.1085/jgp.201411199. Epub 2014 Jul 14.

5.
6.
7.
8.

Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis.

Struyk AF, Markin VS, Francis D, Cannon SC.

J Gen Physiol. 2008 Oct;132(4):447-64. doi: 10.1085/jgp.200809967.

9.

Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.

Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, Lerche H, Nicole S, Vale-Santos J, Chauveau D, Fontaine B, Lehmann-Horn F.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9549-54.

10.

Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation.

Fan C, Lehmann-Horn F, Weber MA, Bednarz M, Groome JR, Jonsson MK, Jurkat-Rott K.

Brain. 2013 Dec;136(Pt 12):3775-86. doi: 10.1093/brain/awt300. Epub 2013 Nov 15.

11.

Stac3 enhances expression of human CaV1.1 in Xenopus oocytes and reveals gating pore currents in HypoPP mutant channels.

Wu F, Quinonez M, DiFranco M, Cannon SC.

J Gen Physiol. 2018 Mar 5;150(3):475-489. doi: 10.1085/jgp.201711962. Epub 2018 Jan 31.

12.

Voltage-sensor mutations in channelopathies of skeletal muscle.

Cannon SC.

J Physiol. 2010 Jun 1;588(Pt 11):1887-95. doi: 10.1113/jphysiol.2010.186874. Epub 2010 Feb 15. Review.

13.

Elevated resting H+ current in the R1239H type 1 hypokalaemic periodic paralysis mutated Ca2+ channel.

Fuster C, Perrot J, Berthier C, Jacquemond V, Allard B.

J Physiol. 2017 Oct 15;595(20):6417-6428. doi: 10.1113/JP274638. Epub 2017 Sep 24.

14.

Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis.

Wu F, Mi W, Cannon SC.

Neurology. 2013 Mar 19;80(12):1110-6. doi: 10.1212/WNL.0b013e3182886a0e. Epub 2013 Feb 20.

15.

Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity.

Kuzmenkin A, Hang C, Kuzmenkina E, Jurkat-Rott K.

Pflugers Arch. 2007 Jun;454(3):495-505. Epub 2007 Feb 27.

PMID:
17333249
17.

Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?

Matthews E, Hanna MG.

J Physiol. 2010 Jun 1;588(Pt 11):1879-86. doi: 10.1113/jphysiol.2009.186627. Epub 2010 Feb 1. Review.

18.

Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.

Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D, Tabti N, Lehmann-Horn F, Hainque B, Fontaine B.

Brain. 2001 Jun;124(Pt 6):1091-9.

PMID:
11353725
20.

Na leak with gating pore properties in hypokalemic periodic paralysis V876E mutant muscle Ca channel.

Fuster C, Perrot J, Berthier C, Jacquemond V, Charnet P, Allard B.

J Gen Physiol. 2017 Dec 4;149(12):1139-1148. doi: 10.1085/jgp.201711834. Epub 2017 Nov 7.

Supplemental Content

Support Center